MedTrace Logo

Oxytocin Dosage to Decrease Induction Duration

NCT03140488 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2022-12-20

Study results available
· View outcomes & findings →

Summary

This is a randomized controlled trial in which women are allocated either 'high dose' or 'low dose' oxytocin infusions for induction of labour. The randomization is stratified by maternal body mass index.

Conditions

Interventions

DRUG

Oxytocin

Patients will be randomized to low dose or high dose oxytocin for induction of labor.

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Principal Investigators

  • Meghan Hill, MBBS · University of Arizona

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-05
Primary Completion
2018-10-12
Completion
2019-09-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03140488 on ClinicalTrials.gov